Literature DB >> 8703710

Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat.

U S Alon1, R A Kaplan, L L Gratny, M A Nichols.   

Abstract

The long-term prognosis of furosemide-associated nephrocalcinosis in the infant is still unclear. Although discontinuation of the diuretic often results in radiological resolution of the calcifications, functional abnormalities may persist. The natural history of the renal histopathology of these patients is yet unknown. In the present study we investigated the histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. Thirty-six weanling male Sprague-Dawley rats were divided into three groups: A controls, B furosemide given for 8 weeks, and C furosemide given for 2 weeks followed by 6 weeks of observation. Metabolic studies at the end of the experiment demonstrated a significant diuretic and natriuretic effect in group B. Kidney histology showed nephrocalcinosis scores (mean +/- SD) of 0.0 +/- 0.0 in A, 2.6 +/- 1.5 in B, and 0.8 +/- 0.6 in C, with B significantly higher than A and C, and C greater than A. Kidney calcium content in B (3,421.9 +/- 2,558.7 micrograms/g dry tissue) was significantly greater than in A (310.4 +/- 21.3) and C (1470.1 +/- 932.2). Another group of 6 rats receiving 2 weeks treatment of furosemide showed a nephrocalcinosis score of 2.2 +/- 1.5, not different from group B, and an additional group of 6 rats treated with furosemide for 2 weeks and observed for another 12 weeks showed a score of 1.3 +/- 0.4, not different from group C. We conclude that most of the renal calcifications induced by furosemide occur during the early days of treatment and that up to 12 weeks after discontinuation of the diuretic, the resolution of the calcifications is only partial.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703710     DOI: 10.1007/BF00862074

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

Review 1.  Nephrocalcinosis.

Authors:  N D Adams; J C Rowe
Journal:  Clin Perinatol       Date:  1992-03       Impact factor: 3.430

2.  Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.

Authors:  G J Downing; J C Egelhoff; D K Daily; M K Thomas; U Alon
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

3.  Renal calcification in preterm infants: pathophysiology and long-term sequelae.

Authors:  F Ezzedeen; R D Adelman; C E Ahlfors
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

4.  The incidence of renal calcification in preterm infants.

Authors:  A Short; R W Cooke
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

5.  Phosphorus-induced nephrocalcinosis in female rats: a study on regression and clinical abnormalities.

Authors:  S J Soeterboek; J Ritskes-Hoitinga; A G Lemmens; A C Beynen
Journal:  Lab Anim       Date:  1991-07       Impact factor: 2.471

6.  Renal calcifications: a complication of long-term furosemide therapy in preterm infants.

Authors:  K G Hufnagle; S N Khan; D Penn; A Cacciarelli; P Williams
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

7.  Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as independent risk factors.

Authors:  M G Karlowicz; M E Katz; R D Adelman; M J Solhaug
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

8.  Renal calcification incidence in very low birth weight infants.

Authors:  J S Jacinto; H D Modanlou; M Crade; A A Strauss; S K Bosu
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

9.  Nephrocalcinosis in very low birth weight neonates: sonographic patterns, histologic characteristics, and clinical risk factors.

Authors:  M E Katz; M G Karlowicz; R D Adelman; A L Werner; M J Solhaug
Journal:  J Ultrasound Med       Date:  1994-10       Impact factor: 2.153

10.  Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse.

Authors:  U Alon; D L Donaldson; S Hellerstein; B A Warady; D J Harris
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

View more
  4 in total

Review 1.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

2.  Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

3.  Furosemide, orlistat and non-steroidal anti-inflammatory agents-too much for the kidneys to handle!

Authors:  Asher Korzets; Uzi Gafter; Ana Tobar; Avri Chagnac; Boris Zingerman; Yaacov Ori
Journal:  NDT Plus       Date:  2009-01-26

4.  Development of an animal model of nephrocalcinosis via selective dietary sodium and chloride depletion.

Authors:  Shamir Tuchman; Laureano D Asico; Crisanto Escano; Daniel A Bobb; Patricio E Ray
Journal:  Pediatr Res       Date:  2012-11-22       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.